CATS Tonometer IOP Reduction Latanoprost Verses Timolol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2019-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

NCT01426464

Glaucoma

UNKNOWN PHASE2

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

NCT04412096

Glaucoma OHT - Ocular Hypertension

COMPLETED PHASE4

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

NCT00716742

Open-Angle Glaucoma Ocular Hypertension

COMPLETED

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00872651

Open-angle Glaucoma Ocular Hypertension

COMPLETED PHASE3

Comparison of Latanoprost Vs. Timolol

NCT00579969

Glaucoma

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This clinical trial is a prospective, controlled, study and will be performed at one clinical investigative site in Tucson Arizona1. The purpose of this study is to determine if the device, CATS tonometer prism, measures intraocular pressure significantly differently than the current standard of care tonometer prism (Goldmann) before and after institution of topical prostaglandin analogs (PGA) for glaucoma treatment. Fifty percent of patients will be randomly placed on topical beta blockers as a control. The difference PGAs and beta blockers would be a measurement of the amount of corneal biomechanical changes made due to the PGA controlled for the effect of IOP lowering by the beta -blocker group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma; Drugs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lataprost

latanoprost use

Group Type ACTIVE_COMPARATOR

CATS Tonometer

Intervention Type DEVICE

latanoprost vs. timolol

timolol

timolol group

Group Type ACTIVE_COMPARATOR

CATS Tonometer

Intervention Type DEVICE

latanoprost vs. timolol

Latanoprost

Intervention Type DRUG

latanoprost IOP reduction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CATS Tonometer

latanoprost vs. timolol

Intervention Type DEVICE

Latanoprost

latanoprost IOP reduction

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

latanoprost v. timolol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Male and female patients, at least 18 years of age

* Subject has a clear understanding and agrees to all the conditions of the informed consent form

Exclusion Criteria

* Subject has undergone ocular surgery within the last 3 months
* Uncontrolled systemic disease that in the opinion of the Investigator would put the subject's heath at risk
* Pregnant or nursing women
* Those who have had corneal surgery including corneal laser surgery
* Microphthalmos
* Buphthalmos
* Severe Dry eyes
* Lid squeezers - blepharospasm
* Nystagmus
* corneal or conjunctival infection.

Minimum Eligible Age

18 Years

Maximum Eligible Age

101 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes